On this examine, an try was made to develop a real-time management technique utilizing oxidation-reduction potential (ORP) and pH (mV) time profiles for the environment friendly operation of bio-liquor circulation system (BCS) in swine farms and its effectiveness in lowering odor emission by enhancing manure properties within the slurry pit was evaluated. The lab-scale BCS used on this examine comprised a bioreactor and a slurry pit. The bioreactor was operated in a sequence of influx of swine manure ® anoxic part ® cardio part ® circulation to the slurry pit. The development in swine manure properties was elucidated by evaluating the outcomes of the BCS slurry pit (circulation kind, CT) and traditional slurry pit (non-circulation kind, NCT).
The outcomes revealed that the ORP time profile efficiently detected the nitrate knee level (NKP) within the anoxic part. Nevertheless, it was much less secure in detecting the nitrogen break level (NBP) within the cardio part. The pH (mV) time profile confirmed a extra environment friendly detection of NBP. In comparison with the NCT slurry pit, concentrations of ammonium nitrogen (NH4-N) and soluble complete natural carbon (STOC) and different analyzed swine manure properties had been a lot decrease within the CT slurry pit. Within the side of odor discount, round 98.3% of NH3 was eliminated within the CT slurry pit. The true-time managed BCS can overcome the drawbacks of fastened time-based BCS operation and subsequently may be thought of as a useful gizmo to scale back odor emission from intensive swine farming operations. Nevertheless, additional research and refinement in management algorithms is likely to be required previous to its large-scale utility.
A cross scale investigation of galena oxidation and controls on mobilization of lead in mine waste rock
Galena and Pb-bearing secondary phases are the principle sources of Pb within the terrestrial atmosphere. Oxidative dissolution of galena releases aqueous Pb and SO4 to the surficial atmosphere and generally causes the formation of anglesite (in acidic environments) or cerussite (in alkaline environments). Nevertheless, circumstances prevalent in weathering environments are various and completely different response mechanisms mirror this variability at numerous scales. Right here we utilized complementary methods throughout a variety of scales, from nanometers to 10 s of meters, to check the oxidation of galena and accumulation of secondary phases that affect the discharge and mobilization of Pb inside a sulfide-bearing waste-rock pile.
Inside the neutral-pH pore-water atmosphere, the oxidation of galena releases Pb ions ensuing within the formation of secondary Pb-bearing carbonate precipitates. Cerussite is the dominant part and shannonite is a doable minor part. Dissolved Cu from the pore water reacts on the floor of galena, forming covellite on the interface. Nanometer scale characterization means that secondary covellite is intergrown with secondary Pb-bearing carbonates on the interface. A small quantity of the S derived from galena is sequestered with the secondary covellite, however the majority of the S is oxidized to sulfate and launched to the pore water.
Two completely different approaches of microbial group construction characterization in riverine epilithic biofilms beneath a number of stressors circumstances: growing molecular indicators
Microbial communities are main gamers within the biogeochemical processes and ecosystem functioning of river networks. Regardless of their significance within the ecosystem, biomonitoring instruments counting on prokaryotes are nonetheless missing. Only some research have employed each metabarcoding and quantitative methods equivalent to Catalyzed reported deposition fluorescence in situ hybridization (CARD-FISH) to analyse prokaryotic communities of epilithic biofilms in river ecosystems. We meant to research the efficacy of each methods in detecting adjustments in microbial group construction related to environmental drivers.
We report a big correlation between the prokaryotic group composition and pH in rivers from two completely different geographical areas in Norway. Each, CARD-FISH and metabarcoding information, had been following the sample of the environmental variables, however the principle function distinguishing the group composition was the regional distinction itself. Beta-dispersion analyses on each, CARD-FISH abundance and metabarcoding information, revealed increased accuracy of metabarcoding to distinguish areas and river programs. The CARD-FISH outcomes confirmed excessive variability, even for samples throughout the similar river, in all probability on account of some unmeasured microscale ecological variability which we couldn’t resolve. We additionally current a statistical technique, which makes use of variation coefficient and total prevalence of taxonomic teams, to detect doable organic indicators amongst prokaryotes utilizing metabarcoding information. The event of latest prokaryotic bioindicators would profit from each methods used on this examine, however metabarcoding appears to be quicker and extra dependable than CARD-FISH for giant scale bio-assessment.
The mixture of thermal stress and ocean acidification (OA) can extra negatively have an effect on coral calcification than a person stressors, however the mechanism behind this interplay is unknown. We used two unbiased strategies (microelectrode and boron geochemistry) to measure calcifying fluid pH (pHcf) and carbonate chemistry of the corals Pocillopora damicornis and Stylophora pistillata grown beneath numerous temperature and pCO2 circumstances. Though these approaches show that they document pHcf over completely different time scales, they reveal that each species can deal with OA beneath optimum temperatures (28°C) by elevating pHcf and aragonite saturation state (Ωcf) in assist of calcification.
 Blocking Peptide) Phospho-Bcr (Ser301) Blocking Peptide |
|
AF7215-BP |
1mg |
EUR 234 |
 Blocking Peptide) Phospho-Bcr (Tyr852) Blocking Peptide |
|
AF7216-BP |
1mg |
EUR 234 |
 Blocking Peptide) Phospho-Bcr (Tyr177) Blocking Peptide |
|
AF3154-BP |
1mg |
EUR 234 |
 Blocking Peptide) Phospho-Bcr (Tyr360) Blocking Peptide |
|
AF3155-BP |
1mg |
EUR 234 |
 Bcr antibody |
|
70R-35600 |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal Bcr antibody |
 BCR antibody |
|
70R-33377 |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal BCR antibody |
Bcr antibody |
|
20R-2043 |
50 ug |
EUR 337.2 |
|
Description: Rabbit polyclonal Bcr antibody |
Bcr antibody |
|
20R-2360 |
50 ug |
EUR 337.2 |
|
Description: Rabbit polyclonal Bcr antibody |
 Bcr Antibody |
|
ABF6154 |
100 ug |
EUR 525.6 |
Bcr Antibody |
|
ABF6155 |
100 ug |
EUR 525.6 |
Bcr Antibody |
|
AF7715 |
200ul |
EUR 540 |
Bcr Antibody |
|
AF7716 |
200ul |
EUR 540 |
 BCR Antibody |
|
1-CSB-PA000989 |
|
|
|
|
|
Description: A polyclonal antibody against BCR. Recognizes BCR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000 |
BCR Antibody |
|
1-CSB-PA000990 |
|
|
|
|
|
Description: A polyclonal antibody against BCR. Recognizes BCR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000 |
BCR Antibody |
|
1-CSB-PA552207 |
|
|
|
|
|
Description: A polyclonal antibody against BCR. Recognizes BCR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100 |
Bcr Antibody |
|
AF6154 |
200ul |
EUR 420 |
Bcr Antibody |
|
AF6155 |
200ul |
EUR 420 |
BCR Antibody |
|
1-CSB-PA196525 |
|
|
|
|
|
Description: A polyclonal antibody against BCR. Recognizes BCR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100 |
 Substance P reversed sequence Peptide |
|
20-abx266314 |
-
EUR 594.00
-
EUR 978.00
-
EUR 427.20
|
|
|
|
 Erythropoietin Mimetic Peptide Sequence 20 |
|
H-4344.0001 |
1.0mg |
EUR 544.8 |
|
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net |
Erythropoietin Mimetic Peptide Sequence 20 |
|
H-4344.0005 |
5.0mg |
EUR 2067.6 |
|
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net |
) Bcr antibody (Tyr177) |
|
70R-37269 |
100 ug |
EUR 418.8 |
|
Description: Rabbit Polyclonal Bcr antibody (Tyr177) |
Bcr antibody (Tyr177) |
|
70R-35040 |
100 ug |
EUR 392.4 |
|
Description: Purified Rabbit polyclonal Bcr antibody (Tyr177) |
) BCR antibody (Tyr360) |
|
70R-33376 |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal BCR antibody (Tyr360) |
 Antibody) BCR (pY360) Antibody |
|
20-abx133129 |
-
EUR 376.80
-
EUR 560.40
-
EUR 243.60
|
|
|
|
 Bcr Polyclonal Antibody |
|
ABP50765-003ml |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Bcr from Human, Mouse. This Bcr antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcr around the non-phosphorylation site of Y177 |
Bcr Polyclonal Antibody |
|
ABP50765-01ml |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Bcr from Human, Mouse. This Bcr antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcr around the non-phosphorylation site of Y177 |
Bcr Polyclonal Antibody |
|
ABP50765-02ml |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Bcr from Human, Mouse. This Bcr antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcr around the non-phosphorylation site of Y177 |
Bcr Polyclonal Antibody |
|
ABP50766-003ml |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Bcr from Human, Mouse. This Bcr antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcr around the non-phosphorylation site of Y360 |
Bcr Polyclonal Antibody |
|
ABP50766-01ml |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Bcr from Human, Mouse. This Bcr antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcr around the non-phosphorylation site of Y360 |
Bcr Polyclonal Antibody |
|
ABP50766-02ml |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Bcr from Human, Mouse. This Bcr antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Bcr around the non-phosphorylation site of Y360 |
 Antibody) BCR (pY177) Antibody |
|
20-abx000257 |
-
EUR 594.00
-
EUR 844.80
-
EUR 427.20
|
|
|
|
 Antibody) Bcr (pY177) Antibody |
|
20-abx119490 |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
|
BCR (pY177) Antibody |
|
20-abx123352 |
-
EUR 594.00
-
EUR 844.80
-
EUR 260.40
-
EUR 427.20
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Bcr Polyclonal Antibody |
|
ES1764-100ul |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Bcr from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Bcr Polyclonal Antibody |
|
ES1764-50ul |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Bcr from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Bcr Polyclonal Antibody |
|
ES1765-100ul |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Bcr from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Bcr Polyclonal Antibody |
|
ES1765-50ul |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Bcr from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
 anti- BCR antibody |
|
FNab00854 |
100µg |
EUR 702 |
|
|
|
Description: Antibody raised against BCR |
 Anti-Bcr Antibody |
|
PB9988 |
100ug/vial |
EUR 352.8 |
 Anti-BCR antibody |
|
STJ110899 |
100 µl |
EUR 332.4 |
|
Description: A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac. Two transcript variants encoding different isoforms have been found for this gene. |
 Anti-Bcr antibody |
|
STJ91846 |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to Bcr. |
Anti-Bcr antibody |
|
STJ91847 |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to Bcr. |
5 peptide (repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide) (NANP)5 peptide (repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide |
|
NANP51-P |
1 mg |
EUR 416.4 |
3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) control/blocking peptide) (PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) control/blocking peptide |
|
PPPP321-P |
100 ug |
EUR 196.8 |
4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide) (NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide |
|
NVDP41-P |
100 ug |
EUR 196.8 |
 matrix protein 2 hybrid sequence Control/blocking peptide) Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide |
|
M2E11-P |
100 ug |
EUR 196.8 |
3 (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) control/blocking peptide) (DRAAGQPAG)3 (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) control/blocking peptide |
|
DRAA31-P |
100 ug |
EUR 196.8 |
 EBFP antibody Blocking Peptide |
|
BF0706-BP |
1mg |
EUR 234 |
 LC3A antibody Blocking Peptide |
|
BF0707-BP |
1mg |
EUR 234 |
 HSC70 antibody Blocking Peptide |
|
BF0712-BP |
1mg |
EUR 234 |
 PARP antibody Blocking Peptide |
|
BF0719-BP |
1mg |
EUR 234 |
 Transferrin antibody Blocking Peptide |
|
BF0720-BP |
1mg |
EUR 234 |
 EYFP antibody Blocking Peptide |
|
BF0725-BP |
1mg |
EUR 234 |
 Rubisco antibody Blocking Peptide |
|
BF0726-BP |
1mg |
EUR 234 |
 C-Peptide Blocking Peptide |
|
3277BP-50 |
each |
EUR 183.6 |
 anti-BCR |
|
YF-PA10456 |
50 ul |
EUR 435.6 |
|
Description: Mouse polyclonal to BCR |
anti-BCR |
|
YF-PA10457 |
100 ug |
EUR 483.6 |
|
Description: Rabbit polyclonal to BCR |
anti-BCR |
|
YF-PA27172 |
50 ug |
EUR 435.6 |
|
Description: Mouse polyclonal to BCR |
 Antibody) Bcr (Phospho-Tyr177) Antibody |
|
11199-100ul |
100ul |
EUR 302.4 |
Bcr (Phospho-Tyr177) Antibody |
|
11199-50ul |
50ul |
EUR 224.4 |
 Antibody) Bcr (Phospho-Ser301) Antibody |
|
13073-100ul |
100ul |
EUR 302.4 |
Bcr (Phospho-Ser301) Antibody |
|
13073-50ul |
50ul |
EUR 224.4 |
 Antibody) Bcr (Phospho-Tyr852) Antibody |
|
13074-100ul |
100ul |
EUR 302.4 |
Bcr (Phospho-Tyr852) Antibody |
|
13074-50ul |
50ul |
EUR 224.4 |
 Antibody) Bcr (Phospho-Tyr360) Antibody |
|
11972-100ul |
100ul |
EUR 302.4 |
Bcr (Phospho-Tyr360) Antibody |
|
11972-50ul |
50ul |
EUR 224.4 |
 Antibody) Phospho- Bcr (Tyr177) Antibody |
|
ABF3154 |
100 ug |
EUR 525.6 |
 Antibody) Phospho- Bcr (Tyr360) Antibody |
|
ABF3155 |
100 ug |
EUR 525.6 |
) Polyclonal Bcr Antibody (Y177) |
|
APR00463G |
0.1 mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Bcr (Y177). This antibody is tested and proven to work in the following applications: |
 Antibody) Phospho-Bcr (Ser301) Antibody |
|
AF7215 |
200ul |
EUR 540 |
 Antibody) Phospho-Bcr (Tyr852) Antibody |
|
AF7216 |
200ul |
EUR 540 |
 Antibody) Phospho-BCR (Y177) Antibody |
|
1-CSB-PA000486 |
|
|
|
|
|
Description: A polyclonal antibody against Phospho-BCR (Y177). Recognizes Phospho-BCR (Y177) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
 Antibody) Phospho-BCR (Tyr177) Antibody |
|
CSB-PA899546-100ul |
100ul |
EUR 434.4 |
|
|
|
Description: A polyclonal antibody against Phospho-BCR (Tyr177). Recognizes Phospho-BCR (Tyr177) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:100 |
 Antibody) BCR (Ab-177) Antibody |
|
CSB-PA929167-100ul |
100ul |
EUR 379.2 |
|
|
|
Description: A polyclonal antibody against BCR (Ab-177). Recognizes BCR (Ab-177) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:1000, IF:1:100-1:200 |
 Antibody) Phospho-BCR (Tyr360) Antibody |
|
CSB-PA950927-100ul |
100ul |
EUR 434.4 |
|
|
|
Description: A polyclonal antibody against Phospho-BCR (Tyr360). Recognizes Phospho-BCR (Tyr360) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
 Antibody) Phospho-Bcr (Tyr177) Antibody |
|
AF3154 |
200ul |
EUR 420 |
 Antibody) Phospho-Bcr (Tyr360) Antibody |
|
AF3155 |
200ul |
EUR 420 |
 Antibody) Phospho-BCR (Y360) Antibody |
|
1-CSB-PA040236 |
|
|
|
|
|
Description: A polyclonal antibody against Phospho-BCR (Y360). Recognizes Phospho-BCR (Y360) from Human, Mouse, Monkey. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000 |
Phospho-BCR (Tyr177) Antibody |
|
CSB-PA899546- |
each |
EUR 402 |
|
|
|
Description: A polyclonal antibody against Phospho-BCR (Tyr177). Recognizes Phospho-BCR (Tyr177) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:100 |
BCR (Ab-177) Antibody |
|
CSB-PA929167- |
each |
EUR 402 |
|
|
|
Description: A polyclonal antibody against BCR (Ab-177). Recognizes BCR (Ab-177) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:1000, IF:1:100-1:200 |
Phospho-BCR (Tyr360) Antibody |
|
CSB-PA950927- |
each |
EUR 402 |
|
|
|
Description: A polyclonal antibody against Phospho-BCR (Tyr360). Recognizes Phospho-BCR (Tyr360) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
 Hsp70 Blocking Peptide |
|
33R-10632 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Hsp70 antibody, catalog no. 70R-11611 |
 SIRT7 Blocking Peptide |
|
33R-10633 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIRT7 antibody, catalog no. 70R-11612 |
 MAPKAPK2 Blocking Peptide |
|
33R-10634 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MAPKAPK2 antibody, catalog no. 70R-11613 |
 CD339 Blocking Peptide |
|
33R-10635 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD339 antibody, catalog no. 70R-11614 |
 PKA Blocking Peptide |
|
33R-10637 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PKA antibody, catalog no. 70R-11621 |
 Raf1 Blocking Peptide |
|
33R-10638 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Raf1 antibody, catalog no. 70R-11622 |
 Wee1 Blocking Peptide |
|
33R-10639 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Wee1 antibody, catalog no. 70R-11626 |
 IHH Blocking Peptide |
|
33R-1064 |
100 ug |
EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SLC26A1 antibody, catalog no. 70R-6562 |
 GSTP1 Blocking Peptide |
|
33R-10640 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GSTP1 antibody, catalog no. 70R-11628 |
 TNFR1 Blocking Peptide |
|
33R-10641 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TNFR1 antibody, catalog no. 70R-11629 |
 LSD1 Blocking Peptide |
|
33R-10642 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LSD1 antibody, catalog no. 70R-11631 |
 STAT1 Blocking Peptide |
|
33R-10643 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of STAT1 antibody, catalog no. 70R-11633 |
 MAK10 Blocking Peptide |
|
33R-10644 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MAK10 antibody, catalog no. 70R-11634 |
 ACADM Blocking Peptide |
|
33R-10647 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADM antibody, catalog no. 70R-11637 |
 ACADL Blocking Peptide |
|
33R-10649 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADL antibody, catalog no. 70R-11639 |
 SLC26A1 Blocking Peptide |
|
33R-1065 |
100 ug |
EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody, catalog no. 70R-1508 |
 ACADSB Blocking Peptide |
|
33R-10650 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADSB antibody, catalog no. 70R-11649 |
ACADSB Blocking Peptide |
|
33R-10651 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADSB antibody, catalog no. 70R-11656 |
 Survivin Blocking Peptide |
|
33R-10653 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Survivin antibody, catalog no. 70R-11659 |
 Bid Blocking Peptide |
|
33R-10654 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Bid antibody, catalog no. 70R-11670 |
 CD40L Blocking Peptide |
|
33R-10655 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD40L antibody, catalog no. 70R-11674 |
 cIAP1 Blocking Peptide |
|
33R-10656 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP1 antibody, catalog no. 70R-11676 |
cIAP1 Blocking Peptide |
|
33R-10657 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP1 antibody, catalog no. 70R-11675 |
 cIAP2 Blocking Peptide |
|
33R-10658 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP2 antibody, catalog no. 70R-11677 |
 XIAP Blocking Peptide |
|
33R-10659 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of XIAP antibody, catalog no. 70R-11678 |
 CACNB2 Blocking Peptide |
|
33R-1066 |
100 ug |
EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LHPP antibody, catalog no. 70R-4027 |
 Perforin Blocking Peptide |
|
33R-10660 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Perforin antibody, catalog no. 70R-11680 |
 NIK Blocking Peptide |
|
33R-10665 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NIK antibody, catalog no. 70R-11685 |
 TrkA Blocking Peptide |
|
33R-10666 |
50 ug |
EUR 229.2 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TrkA antibody, catalog no. 70R-11686 |
At 31°C, neither species elevated these parameters as they did at 28°C and, likewise, couldn’t keep considerably optimistic calcification charges beneath any pH remedy. These outcomes reveal a beforehand uncharacterized affect of temperature on coral pHcf regulation-the obvious mechanism behind the damaging interplay between thermal stress and OA on coral calcification.
